Forcefield Therapeutics

Pioneering Therapeutics to Preserve Heart Function

Founded 2020 · $7.5M raised

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$7.5M
Last Round
$7.5M Venture RoundApr 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Forcefield Therapeutics is pioneering therapeutics to preserve heart function and revolutionise the treatment of heart attacks. The company develops first-in-class therapeutics to retain heart function via protection of cardiomyocytes. Forcefield’s approach can protect heart cells, minimising the impact of a heart attack (myocardial infarction or MI) and preventing the cascade of events that may lead to subsequent heart failure. Cardiovascular disease remains the greatest global health problem, and myocardial infarction is the most common cause of heart failure worldwide.

Summary

Forcefield Therapeutics is a Biotech company, founded in 2020. It has raised $7.5M in total across 1 round, most recently a $7.5M Venture Round in Apr 2022.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundApr 2022
$7.5M

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Forcefield Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/forcefield-therapeutics"><img src="https://indexed.vc/api/badge/company/forcefield-therapeutics" alt="Forcefield Therapeutics on Indexed.vc" width="260" height="76" /></a>